Skip to content

Cotrimoxazole prophylaxis is cost-effective for people starting ART in sub-Saharan Africa

New vaccine against pneumococcal disease approved for UK

Free cotrimoxazole improves retention in care among adults not yet eligible for ART

HPTN 052: early treatment reduces serious illness by 40%

Beatriz Grinsztejn and Mina Hossienipour ©IAS/Marcus Rose/Worker's Photos

Can a blood test show if an HIV-positive patient has PCP?

Fall in MRSA infection in HIV patients

No reduction in postnatal death or illness with cotrimoxazole prophylaxis for mothers with HIV

Screening ART patients for cryptococcal disease is cost effective and will save lives

Infections the main cause of CNS neurological problems in South African patients starting HIV treatment